Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Performance of NT-proBNP in Risk Stratification for Cardiovascular Events and Mortality in Patients With Diabetes (PISCES)

NCT05745090 is registered in ClinicalTrials.gov with Singapore General Hospital as lead sponsor.

NCT NCT05745090
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05745090 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Performance of NT-proBNP in Risk Stratification for Cardiovascular Events and Mortality in Patients With Diabetes (PISCES)
Lead sponsor
Singapore General Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
November 10, 2022
Completion date
April 30, 2029
Enrollment
1,200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular complication, heart failure, type2diabetes